Location History:
- Chapel Hill, AU (2007 - 2013)
- Queensland, AU (2006 - 2015)
- St. Lucia, AU (2017)
Company Filing History:
9 out of 340 
1 out of 1,333 
1 out of 1,650 
Years Active: 2006-2017
Title: David James Craik: A Trailblazer in Peptide-Based Innovations
Introduction:
In the world of scientific research and innovation, few names stand out quite like that of David James Craik. With a wealth of knowledge in the field of peptides and their potential applications, Craik has made significant contributions to the advancements in treating disorders involving voltage-gated ion channels and receptors. Let us delve deeper into his latest patents, career highlights, and notable collaborations.
Latest Patents:
David James Craik's latest patents showcase his expertise in developing peptide-based therapeutics with potential medical applications. Two notable inventions are:
1. J-superfamily conotoxin peptides: Craik has invented relatively short peptides, known as J-superfamily conotoxin peptides or J-conotoxin peptides, which are naturally found in minute amounts in the venom of cone snails. These peptides, about 25 residues in length and containing two disulfide bonds, have shown potential in treating disorders involving voltage-gated ion channels and receptors.
2. Cyclised alpha-conotoxin peptides: Craik has also developed an oral or enteral pharmaceutical preparation comprising cyclised alpha-conotoxin peptides capable of inhibiting a nicotinic acetylcholine receptor. These peptides, with a cyclised backbone and four cysteine residues forming two disulfide bonds, hold promise for the treatment of various conditions.
Career Highlights:
David James Craik's illustrious career spans across esteemed institutions where his contributions have been invaluable. Some notable highlights include:
1. The University of Queensland: Craik has been associated with the University of Queensland, Australia, where he played a crucial role in fostering research and advancements in peptide-based therapies. His work has not only elevated the institution's reputation but also contributed significantly to the scientific community.
2. University of Utah Research Foundation: As a researcher at the University of Utah Research Foundation, Craik continued to make groundbreaking discoveries and innovations in peptide therapeutics. His work has opened up new avenues for potential treatments and garnered attention from the scientific community worldwide.
Collaborations:
David James Craik's accomplishments have been augmented through fruitful collaborations with fellow experts. Notable amongst them are:
1. Norelle Lee Daly: Craik's work has seen collaboration with the esteemed Norelle Lee Daly, who has been an influential researcher in the field of peptide-based drug development. Together, they have contributed towards expanding the knowledge base of peptide-based pharmacology.
2. Katherine Justine Nielsen: Craik's collaboration with Katherine Justine Nielsen has further contributed to advancements in their shared vision for peptide-based therapies. Their combined efforts have paved the way for potential breakthroughs in treating disorders involving voltage-gated ion channels and receptors.
Conclusion:
David James Craik's extensive expertise in peptides and their applications has undoubtedly fueled significant advancements in the field of medicinal research. With eight patents under his belt, his latest inventions, such as J-superfamily conotoxin peptides and cyclised alpha-conotoxin peptides, exemplify his commitment to developing innovative solutions for complex medical conditions. As he continues to forge new pathways, Craik's contributions will continue to impact the scientific and medical communities positively.